NHS Dudley Health Economy Medicines Formulary
Home > 6 Endocrine system > 6.1 Drugs used in diabetes > 6.1.2 Antidiabetic drugs

6.1.2 Antidiabetic drugs

Click here for Dudley Diabetes Guidelines

Recommended drugs

Metformin tablets £

Metformin modifed release  ££ (where patient has intolerable gastrointestinal effects on metformin immediate release)

Metformin 500mg/5ml sugar free oral solution £££££ (where patient unable to swallow tablets)

Sulphonylureas:

Gliclazide £

Glimepiride £

Rapid-acting insulin secretagogues

Nateglinide

Repaglinide

Thiazolidinedione:

Pioglitazone £

DPP-4 (dipeptidylpeptidase-4):

Alogliptin £

Sitagliptin £££

Linagliptin £££ (where renal function is a concern) 

SGLT-2 (sodium glucose co-transporter 2):

Canaglifozin £££

Dapaglifozin £££

Empagliflozin £££

GLP-1 (glucagon-like-peptide-1) agonists

Lixisenatide £££££

Exenatide £££££

Liraglutide £££££

Dulaglutide £££££

ACE non-approved drugs

Vildagliptin removed from formulary October 2011

Saxagliptin removed from formulary November  2014

 

Drug Traffic Light Key:

Green – On Formulary

Amber – Restricted use, see local guidelines       

Purple – Specialist use/initiation

Red – Non Formulary

 

Relative Costs Key (where indicated):

£££££ - high

£££ - moderate

£ - low

Site by Devopa
© Copyright 2019 NHS. All rights reserved.